FDA Outlines Criteria for Skipping Trial Consent in Emergencies

Clinical Trials Advisor
New FDA requirements regarding emergency research on incapacitated patients stress that sponsors must attempt to get permission from the patient’s family to continue a trial that was started without consent and allow patients to opt out once they are conscious.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00